Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1995-06-06
1999-04-06
Mertz, Prema
Drug, bio-affecting and body treating compositions
Lymphokine
530351, 530417, 530418, 530420, 435 712, 435 695, 435325, 4352523, 4353201, 435471, C07K 14535, C07K 120, A61K 3819
Patent
active
058914293
ABSTRACT:
A method for preparing and isolating a transformation vector containing CSF/cDNA is described. The method comprises:
REFERENCES:
patent: 4438032 (1984-03-01), Golde et al.
Yunis, et al., FEBS letters, 1978, 90: 279-82.
Wu, et al. J. Biol. Chem., 1979, 254: 6226-28.
Gasson, et al. Science, 1984, 226: 1339-1342.
Fojo, et al., Biochemistry, 1978, 17: 3109-16.
Lusis, et al., Blood, 1981, 57: 13-21.
Nicola, et al., Blood, 1979, 54: 614-27.
Fojo, et al., Biophys. Acts., 1977, 494: 92-99.
Price, et al., Biochem. J., 1975, 148: 209-17.
Metcalf, The Hemopoietic Colony Stimulating Factors, Elsevier (1984), pp. 81-84, 215-227, 309-329.
Gongh et al. (1984) Nature vol. 309, pp. 763-767.
Lusis et al. (1982) Nature vol. 298, pp. 75-77.
Blenckley et al. (1983) Nucleic Acids Research. vol. 11, No. 10, 3027-3035.
Clark Steven C.
Kaufman Randal J.
Wang Elizabeth A.
Wong Gordon G.
Mertz Prema
The Novartis Corporation
LandOfFree
Recombinant human granulocyte-macrophage-colony stimulating fact does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant human granulocyte-macrophage-colony stimulating fact, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant human granulocyte-macrophage-colony stimulating fact will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1368636